Cargando…
Improving Arterial Wall Characteristics in Patients After Myocardial Infarction with a Very Low Dose of Fluvastatin and Valsartan: A Proof-of-Concept Study
BACKGROUND: We tested the concept of improving arterial wall characteristics by treatment with a very low-dose combination of fluvastatin and valsartan (low-flu/val) in stable, post-myocardial infarction (MI) patients. MATERIAL/METHODS: We enrolled 36 post-MI middle-aged males in the treatment (n=20...
Autores principales: | Veselič, Martina Turk, Eržen, Barbara, Hanžel, Jurij, Piletič, Žiga, Šabovič, Mišo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247743/ https://www.ncbi.nlm.nih.gov/pubmed/30266894 http://dx.doi.org/10.12659/MSM.908967 |
Ejemplares similares
-
A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study
por: Hanžel, Jurij, et al.
Publicado: (2015) -
A Low-Dose Combination of Fluvastatin and Valsartan: A New “Drug” and a New Approach for Decreasing the Arterial Age
por: Janić, Miodrag, et al.
Publicado: (2015) -
Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent/Treat “Aging-Related Disorders”
por: Janić, Miodrag, et al.
Publicado: (2019) -
Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden
por: Eržen, Barbara, et al.
Publicado: (2014) -
Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trial
por: Zhao, Zhiqiang, et al.
Publicado: (2020)